Zevia: Telsey Advisory Group maintains Outperform, PT raised to $6 from $5.

Zevia: Telsey Advisory Group maintains Outperform, PT raised to $6 from $5.

Zevia PBC (NYSE: ZVIA) continues to receive positive attention from analysts, with Telsey Advisory Group maintaining its "outperform" rating and raising the price target to $6.00, up from the previous $5.00. This upgrade reflects the company's strong performance during the first quarter of 2025, where it exceeded analyst estimates with a revenue of $38.02 million and an earnings per share of ($0.06) [1].

The stock has shown robust performance, opening at $3.04 on Monday and reaching a 52-week high of $4.99. Institutional investors, including hedge funds such as Outlook Wealth Advisors LLC and Wolverine Trading LLC, have recently increased their stakes in Zevia PBC, indicating a positive outlook among institutional investors [1].

Telsey Advisory Group's upgrade is part of a broader trend of analyst upgrades in the market, with other notable upgrades including Alnylam Pharmaceuticals, Alamo Group, and Apartment Investment and Management Company [2]. While these upgrades suggest a positive sentiment among analysts, it is crucial for investors to conduct thorough research and consider the specific risks associated with each company before making investment decisions.

References:
[1] https://www.marketbeat.com/instant-alerts/zevia-pbc-nysezvia-raised-to-outperform-at-telsey-advisory-group-2025-08-04/
[2] https://www.ainvest.com/news/top-5-analyst-upgrades-monday-alnylam-pharmaceuticals-federated-hermes-zevia-alamo-group-apartment-investment-management-2508/